The COVID-19 vaccine developed by Oxford University and AstraZeneca was 79% effective in preventing symptomatic illness a large trial in the United States, Chile and Peru, the company said on Monday,...
from NDTV News - World-news https://ift.tt/3r8Gv95
No comments:
Post a Comment